<scp>COVID</scp>‐19 convalescent plasma: Interim recommendations from the <scp>AABB</scp>
Claudia S. Cohn, Lise J Estcourt, Brenda J. Grossman, Monica B. Pagano, Elizabeth S. Allen, Evan M. Bloch, Arturo Casadevall, Dana V. Devine, Nancy M. Dunbar, Farid Foroutan, Thomas J. Gniadek, Ruchika Goel, Jed B. Gorlin, Michael J. Joyner, Ryan A. Metcalf, Jay S. Raval, Todd W. Rice, Beth H. Shaz, Ralph R. Vassallo, Jeffrey L. Winters, Gregory Beaudoin, Aaron A.R. Tobian
Abstract
The authors have no substantial conflicts of interest.
Topics & Concepts
Convalescent plasmaCoronavirus disease 2019 (COVID-19)Interim2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyBetacoronavirusMedicineInternal medicinePolitical scienceOutbreakDiseaseInfectious disease (medical specialty)LawCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19